treatment of infection with hepatitis a virus soa alone or in combination with hepatitis delta virus and the associated liver diseases

摘要

The invention concerns the use of cyclophilin inhibitors (such as alisporivir or DEB025) in the treatment of Hepatitis B and Hepatitis D virus infections, optionally in combination with interferon or telbivudine, lamivudine, emtricitabine, entecavir, adefovir or tenofovir.